Business

0 Comments
The recent Food and Drug Administration (FDA) approval of Merck’s new vaccine, Capvaxive, marks a significant breakthrough in protecting adults from a bacteria known as pneumococcus. This bacteria can lead to serious illnesses, including pneumonia, making the development of an effective vaccine crucial for public health. Capvaxive is designed to specifically protect against 21 strains
0 Comments
Eli Lilly has been experiencing a surge in demand for their weight loss and diabetes treatments, leading to significant growth in revenue and investor optimism. The company’s outgoing Chief Financial Officer, Anat Ashkenazi, has been instrumental in managing this success. However, despite this achievement, Ashkenazi acknowledges that there is still much work to be done.
0 Comments
Disney and Pixar have once again demonstrated their prowess at the box office with the release of “Inside Out 2.” The animated film made a significant impact, debuting with an estimated $155 million domestically. This impressive opening marks the second-highest theatrical opening for an animated film, indicating a strong resurgence for the genre. It is
0 Comments
Major League Eating shocked fans and competitors alike with the recent announcement that they will be parting ways with the legendary Joey “Jaws” Chestnut ahead of this year’s Nathan’s Famous Fourth of July hot dog eating contest. The decision comes as a surprise to many, especially considering Chestnut’s impressive track record as a 16-time champion
0 Comments
Recently, a panel of independent advisors to the Food and Drug Administration recommended Eli Lilly’s Alzheimer’s drug donanemab for full approval in the United States. This recommendation marks a significant milestone in the fight against Alzheimer’s disease, offering new hope to patients and their families who are impacted by this devastating condition. Alzheimer’s disease affects